We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
126
Ascendis Pharma A/S
ASND
$16.3B
$32.1M 0.2%
238,422
-11,977
-5% -$1.78M
MTD icon
127
Mettler-Toledo International
MTD
$27.9B
$31.6M 0.2%
18,642
+297
+2% +$449K
HCA icon
128
HCA Healthcare
HCA
$89.6B
$31.3M 0.2%
121,710
+96,759
+388% +$23.7M
ARNA
129
DELISTED
Arena Pharmaceuticals Inc
ARNA
$30.1M 0.19%
324,079
-302,239
-48% -$19.9M
RHI icon
130
Robert Half
RHI
$4.18B
$29.4M 0.19%
263,738
+67,868
+35% +$7.56M
SWK icon
131
Stanley Black & Decker
SWK
$14.9B
$28.9M 0.18%
153,335
+50,180
+49% +$9.27M
IONS icon
132
Ionis Pharmaceuticals
IONS
$9.06B
$28.5M 0.18%
936,635
+210,276
+29% +$6.62M
HALO icon
133
Halozyme
HALO
$9.96B
$28.4M 0.18%
705,079
+7,100
+1% +$265K
WST icon
134
West Pharmaceutical
WST
$23.7B
$28.3M 0.18%
60,439
+6,571
+12% +$2.83M
PEP icon
135
PepsiCo
PEP
$194B
$28.3M 0.18%
163,008
-14,435
-8% -$2.36M
POWI icon
136
Power Integrations
POWI
$3.35B
$28.2M 0.18%
303,064
+59,485
+24% +$5.84M
SAIL
137
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$27.6M 0.18%
570,118
-165,607
-23% -$8.12M
TPTX
138
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$27.5M 0.18%
575,488
+54,863
+11% +$2.45M
MTZ icon
139
MasTec
MTZ
$24.9B
$27M 0.17%
292,960
-16,233
-5% -$1.48M
TX icon
140
Ternium
TX
$9.75B
$26.5M 0.17%
607,983
-411,717
-40% -$17.3M
NBIX icon
141
Neurocrine Biosciences
NBIX
$18.2B
$26.4M 0.17%
309,913
+228,400
+280% +$21M
INSM icon
142
Insmed
INSM
$22.7B
$26.3M 0.17%
965,755
+86,208
+10% +$2.46M
NUAN
143
DELISTED
Nuance Communications, Inc.
NUAN
$26.2M 0.17%
474,152
– –
PFE icon
144
Pfizer
PFE
$144B
$26.2M 0.17%
443,077
+309,129
+231% +$15.3M
CDNS icon
145
Cadence Design Systems
CDNS
$96.1B
$26.1M 0.17%
139,919
-33,283
-19% -$5.8M
SEDG icon
146
SolarEdge
SEDG
$2.42B
$25.8M 0.16%
91,940
+2,429
+3% +$767K
KYMR icon
147
Kymera Therapeutics
KYMR
$8.78B
$25.6M 0.16%
402,819
+7,828
+2% +$456K
ELV icon
148
Elevance Health
ELV
$82.5B
$25.3M 0.16%
54,542
-1,808
-3% -$761K
MKC icon
149
McCormick & Company Non-Voting
MKC
$13.8B
$25M 0.16%
258,706
-10,595
-4% -$902K
PNC icon
150
PNC Financial Services
PNC
$100B
$24.9M 0.16%
124,385
-44,206
-26% -$9M
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.